Skip to main content

Table 2 SNP-array results of fetal FGR with normal karyotype analysis

From: Fetal growth restriction: associated genetic etiology and pregnancy outcomes in a tertiary referral center

Case

SNP array locus

Size (Mb)

Prenatal ultrasound

Pathogenicity classification

Postnatal outcome

Inheritance

1

arr[hg19]7q11.23(72,723,370–74,143,240) × 1

1.4

FGR

P

TP

2

arr[hg19]15q14q21.3(35,077,111–54,347,324)hmz

19.2

FGR, polyhydramnios

P (Prader-Willi)

TP

UPD (Maternal)

3

arr[hg19]10q11.22q11.23(46,252,072–51,903,756) × 1

5.6

FGR, echogenic bowel

P

TP

de novo

4

arr[hg19]8q11.23q12.1(54,456,444–59,599,862) × 1

5.1

FGR, single umbilical artery, oligohydramnios

Likely P

TP

5

arr[hg19]6p25.3q27(203,877–170,896,644) × 2 hmz

FGR, echogenic bowel, mild tricuspid regurgitation, reverse ductus alpha wave

P

TP

UPD (Paternal)

6

arr[hg19]4p16.3p16.1(68,345–6,608,624) × 1

6.5

FGR, pulmonary stenosis

P (Wolf-Hirschhorn)

TP

7

arr[hg19]15q24.1q24.2(72,965,465–75,567,135) × 1

2.6

FGR, VSD, pulmonary valve stenosis with insufficiency

P (15q24 microdeletion syndrome)

TP

de novo

8

arr[hg19]16q23.3q24.3(79,800,878–90,146,366) × hmz,16p13.3p12.3(94,807–19,302,326) × hmz

10.3

19.2

FGR, VSD, aortarctia, left kidney dysplasia

Likely P

TP

9

arr[hg19]22q11.21(18,648,855–21,459,713) × 3

2.8

FGR, intrahepatic portal shunt, umbilical vein tumor like dilatation

P (22q11.21 microduplication)

TP

Maternal

10

arr[hg19]22q11.21(18,648,855–21,800,471) × 1

3.1

FGR, VSD

P (22q11.21 microdeletion syndrome)

TP

11

arr[hg19]17p11.2(16,615,982–18,922,171) × 3

2.1

FGR, VSD

P (Potocki-Lupski)

TP

Maternal

12

arr[hg19]2p25.3p11.2(50,813–87,053,152)hmz,arr[hg19]2q11.1q37.3(95,550,957–242,773,583) hmz

FGR, persistent left superior vena cava, renal parenchyma echo enhancement

Likely P

TP

UPD (Maternal)

13

arr[hg19]22q11.21(18,648,855–21,800,471) × 3

3.1

FGR

VUS

TD

Paternal

14

arr[hg19]4q28.3q31.3(133,718,289–154,569,367)hmz

20.8

FGR

VUS

TD

15

arr[hg19]15q24.1q24.2(72,969,435–75,601,120) × 3

2.6

FGR

VUS

TD

Maternal

16

arr[hg19]14q12(25,364,014–26,860,808) × 3

1.4

FGR

VUS

TD

17

arr[hg19]4q24(106,284,925–107,545,257) × 3

1.2

FGR, VSD

VUS

18

arr[hg19]18p11.23p11.22(7,153,845–8,964,650) × 3

1.8

FGR

Likely B

TD

Paternal

19

arr[hg19]4q35.2(188,155,530–190,957,460) × 1

2.8

FGR, tricuspid regurgitation

Likely B

TD

Maternal

  1. The 19 cases with normal karyotype analysis but SNP-array abnormality included 12 pathogenic CNV, 5 VUS and 1 benign CNV. VSD ventricular septal defect, SNP single-nucleotide polymorphism, FGR fetal growth restriction, P pathogenic, B benign, TP termination of pregnancy, TD term delivery